Literature DB >> 10668904

Temperature modulation (hypothermic and hyperthermic conditions) and its influence on histological and behavioral outcomes following cerebral ischemia.

D Corbett1, J Thornhill.   

Abstract

Core temperature (T(C)) is a critical determinant of the severity of neural damage that results from focal or global ischemia. Former studies indicated that especially intra-ischemic but also post ischemic mild hypothermia significantly decreased necrotic neural damage of a focal or global insult, as assessed between 3-7 days post-insult. More recent work shows that prolonged post-ischemic hypothermia reduces neural damage and inhibits associated behavioral deficits for up to one year after the insult (i.e. true neuroprotection with behavioral preservation). Alternatively, increases in core temperature via external heating or with pyrogens resulting from bacterial infections, at the time of the global ischemia insult worsen the neural damage of ischemic animals from those of respective normothermic controls given the same insult. This is paralleled in the clinical setting whereby approximately 50% of ischemic patients develop fevers within 2 days of the insult and have worsened neurological outcomes than non-febrile patients. The review discusses the possible mechanisms of neuroprotection of hypothermic therapy from cerebral ischemia as well as mechanisms involved in the exacerbation of neural damage of hypoxic ischemia under hyperthermic conditions. Questions are raised as to whether the medical community has sufficient evidence to begin appropriate hypothermic therapy of acute stroke patients. The importance of accurate monitoring core temperatures of all suspected stroke patients is emphasized, noting the differences in temperature that can occur with age, sex, medication or lifestyle so that appropriate temperature treatment could be implemented, if required.

Entities:  

Mesh:

Year:  2000        PMID: 10668904     DOI: 10.1111/j.1750-3639.2000.tb00251.x

Source DB:  PubMed          Journal:  Brain Pathol        ISSN: 1015-6305            Impact factor:   6.508


  27 in total

1.  [Recommendations of the European Stroke Initiative (EUSI) for treatment of ischemic stroke--update 2003. I. organization and acute therapy].

Authors:  Sonja Külkens; Peter Arthur Ringleb; Werner Hacke
Journal:  Nervenarzt       Date:  2004-04       Impact factor: 1.214

2.  Rise of the machines: controlling the body temperature of critically ill patients by endovascular catheters.

Authors:  Stefan Schwab; Rainer Kollmar
Journal:  Neurocrit Care       Date:  2004       Impact factor: 3.210

Review 3.  Neuroprotection for ischemic stroke: past, present and future.

Authors:  Myron D Ginsberg
Journal:  Neuropharmacology       Date:  2008-03-04       Impact factor: 5.250

Review 4.  Experimental models, neurovascular mechanisms and translational issues in stroke research.

Authors:  E H Lo
Journal:  Br J Pharmacol       Date:  2007-12-24       Impact factor: 8.739

5.  Alpha-stat versus pH-stat guided ventilation in patients with large ischemic stroke treated by hypothermia.

Authors:  Rainer Kollmar; Dimitrios Georgiadis; Stefan Schwab
Journal:  Neurocrit Care       Date:  2008-11-11       Impact factor: 3.210

Review 6.  Pathophysiology and neuroprotection of global and focal perinatal brain injury: lessons from animal models.

Authors:  Luigi Titomanlio; David Fernández-López; Lucilla Manganozzi; Raffaella Moretti; Zinaida S Vexler; Pierre Gressens
Journal:  Pediatr Neurol       Date:  2015-01-31       Impact factor: 3.372

7.  Prohibitin viral gene transfer protects hippocampal CA1 neurons from ischemia and ameliorates postischemic hippocampal dysfunction.

Authors:  Hitomi Kurinami; Munehisa Shimamura; Tao Ma; Liping Qian; Kenzo Koizumi; Laibaik Park; Eric Klann; Giovanni Manfredi; Costantino Iadecola; Ping Zhou
Journal:  Stroke       Date:  2014-03-11       Impact factor: 7.914

8.  Effects of buprenorphine and meloxicam analgesia on induced cerebral ischemia in C57BL/6 male mice.

Authors:  Kirsten R Jacobsen; Natasha Fauerby; Zindy Raida; Otto Kalliokoski; Jann Hau; Flemming F Johansen; Klas Sp Abelson
Journal:  Comp Med       Date:  2013-04       Impact factor: 0.982

9.  Blantyre Malaria Project Epilepsy Study (BMPES) of neurological outcomes in retinopathy-positive paediatric cerebral malaria survivors: a prospective cohort study.

Authors:  Gretchen L Birbeck; Malcolm E Molyneux; Peter W Kaplan; Karl B Seydel; Yamikani F Chimalizeni; Kondwani Kawaza; Terrie E Taylor
Journal:  Lancet Neurol       Date:  2010-11-04       Impact factor: 44.182

10.  SMTP-7, a novel small-molecule thrombolytic for ischemic stroke: a study in rodents and primates.

Authors:  Hironobu Sawada; Naoko Nishimura; Eriko Suzuki; Jie Zhuang; Keiko Hasegawa; Hiroyuki Takamatsu; Kazuo Honda; Keiji Hasumi
Journal:  J Cereb Blood Flow Metab       Date:  2013-11-06       Impact factor: 6.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.